ArticleInternational urology and nephrology2026
Temporal trends in mortality attributable to atrial fibrillation among adults with acute renal failure in the United States, 1999-2024.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtrial fibrillation (AF) and acute renal failure (ARF) frequently coexist, creating a bidirectional pathophysiologic interaction that amplifies morbidity and mortality risks. Despite their clinical significance, nationwide trends in AF-associated mortality among patients with ARF remain underexplored in the United States.
methodsUsing mortality data from the CDC WONDER database (1999-2024), we conducted a retrospective analysis of deaths among adults aged 25 years and older with AF (ICD-10: I48) and ARF (ICD-10: N17). Age-adjusted mortality rates (AAMRs) were calculated per 100,000 population using the 2000 U.S. standard population. Temporal trends and annual percent changes (APCs) were assessed using Joinpoint regression analysis.
resultsFrom 1999 to 2024, 139,956 AF-ARF-associated deaths were recorded. AAMRs increased from 0.6 (95% CI 0.6-0.7) in 1999 to 5.0 (95% CI 4.9-5.1) in 2024, peaking during 2019-2022 (APC: + 34.55, p < 0.000001), followed by a significant decline (APC: - 8.55, p = 0.0036). Mortality remained consistently higher in men than women and was greatest among non-Hispanic Whites and American Indians/Alaska Natives. The South and nonmetropolitan regions exhibited the highest regional mortality burdens. State-level disparities showed particularly elevated rates in Kentucky, South Carolina, and Washington.
conclusionsAF-associated mortality among individuals with ARF has risen dramatically over two decades, with a recent partial decline. Persistent sex, racial, and geographic disparities underscore the need for targeted prevention, early identification, and integrated cardio-renal management strategies to mitigate mortality in this high-risk population.
Indexed as
Identifiers
41269481What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.